Journal article · 1999 · Open access

CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue

Michael L. Penn, Jean‐Charles Grivel, Birgit Schramm, Mark A. Goldsmith, Leonid B Margolis

Proceedings of the National Academy of Sciences, 96(2), 663–668 · Published 19 January 1999 · DOI 10.1073/pnas.96.2.663

Open full textView at the publisherCite this paper

In brief

“CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue” is a 1999 journal article by Michael L. Penn and 4 co-authors, published in Proceedings of the National Academy of Sciences. OpenAlex counts 150 citations as of 19 November 2026. It is open access: the full text is free to read at Europe PMC (PubMed Central).

Citations
150
Most cited in
2021 (4)
Field-weighted impact
4.76
References
51
Authors
5

Abstract

The human chemokine receptors CCR5 and CXCR4 have emerged as the predominant cofactors, along with CD4, for cellular entry of HIV-1 in vivo whereas the contribution of other chemokine receptors to HIV disease has not been yet determined. CCR5-specific (R5) viruses predominate during primary HIV-1 infection whereas viruses with specificity for CXCR4 (R5/X4 or X4 viruses) often emerge in late stages of HIV disease. The evolution of X4 viruses is associated with a rapid decline in CD4+ T cells, although a causative relationship between viral tropism and CD4+ T cell depletion has not yet been proven. To rigorously test this relationship, we assessed CD4+ T cell depletion in suspensions of human peripheral blood mononuclear cells and in explants of human lymphoid tissue on exposure to paired viruses that are genetically identical (isogenic) except for select envelope determinants specifying reciprocal tropism for CXCR4 or CCR5. In both systems, X4 HIV-1 massively depleted CD4+ lymphocytes whereas matched R5 viruses depleted such cells only mildly despite comparable viral replication kinetics. These findings demonstrate that the coreceptor specificities of HIV-1 are a causal factor in CD4+ T cell depletion ex vivo and strongly support the hypothesis that the evolution of viral envelope leading to usage of CXCR4 in vivo accelerates loss of CD4+ T cells, causing immunodeficiency.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Penn, M. L., Grivel, J., Schramm, B., Goldsmith, M. A., & Margolis, L. B. (1999). CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proceedings of the National Academy of Sciences, 96(2), 663–668. https://doi.org/10.1073/pnas.96.2.663

MLA 9

Penn, Michael L., et al. “CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue.” Proceedings of the National Academy of Sciences, vol. 96, no. 2, 1999, pp. 663–668. https://doi.org/10.1073/pnas.96.2.663.

Chicago

Penn, Michael L., Jean‐Charles Grivel, Birgit Schramm, Mark A. Goldsmith, and Leonid B Margolis. 1999. “CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue.” Proceedings of the National Academy of Sciences 96 (2): 663–668. https://doi.org/10.1073/pnas.96.2.663.

Harvard

Penn, M. L. et al. (1999) ‘CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue’, Proceedings of the National Academy of Sciences, 96(2), pp. 663–668. doi:10.1073/pnas.96.2.663.

IEEE

M. L. Penn, J. Grivel, B. Schramm, M. A. Goldsmith, and L. B. Margolis, “CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue,” Proceedings of the National Academy of Sciences, vol. 96, no. 2, pp. 663–668, 1999, doi: 10.1073/pnas.96.2.663.

BibTeX

@article{penn1999cxcr,
  title     = {{CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue}},
  author    = {Penn, Michael L. and Grivel, Jean‐Charles and Schramm, Birgit and Goldsmith, Mark A. and Margolis, Leonid B},
  journal   = {Proceedings of the National Academy of Sciences},
  year      = {1999},
  volume    = {96},
  number    = {2},
  pages     = {663--668},
  doi       = {10.1073/pnas.96.2.663},
  url       = {https://doi.org/10.1073/pnas.96.2.663}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201633
201711
201811
201933
202144
202222
202333
202411
202511
202622

Its field-weighted citation impact is 4.76: it has been cited 4.76 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • HIV-1
  • CXCR4
  • CCR5
  • CD4+ T cell depletion
  • viral tropism
  • immunodeficiency

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Penn, M. L., Grivel, J., Schramm, B., Goldsmith, M. A., & Margolis, L. B. (1999). CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proceedings of the National Academy of Sciences, 96(2), 663–668. https://doi.org/10.1073/pnas.96.2.663

How many times has this paper been cited?

150 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.

Who wrote this paper?

Michael L. Penn, Jean‐Charles Grivel, Birgit Schramm, Mark A. Goldsmith, Leonid B Margolis.

What is the DOI of this paper?

10.1073/pnas.96.2.663, permanently at https://doi.org/10.1073/pnas.96.2.663. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.